Pharmaceutical major Zydus Cadila has received final approval from United States Food & Drug Administration (USFDA) for marketing of anti-viral drug Acyclovir.
“Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets,” the company said in a statement issued here today.
The approval has been granted for Acyclovir tablets in strengths of 400 mg and 800 mg, Zydus Cadila said.
According to IMS data, the sales of Acyclovir tablets in 2014 are estimated at USD 55.8 million.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.